Anna Roubtsova

988 total citations
17 papers, 786 citations indexed

About

Anna Roubtsova is a scholar working on Surgery, Molecular Biology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anna Roubtsova has authored 17 papers receiving a total of 786 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Surgery, 9 papers in Molecular Biology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anna Roubtsova's work include Lipoproteins and Cardiovascular Health (12 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Anna Roubtsova is often cited by papers focused on Lipoproteins and Cardiovascular Health (12 papers), Protein Kinase Regulation and GTPase Signaling (4 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (3 papers). Anna Roubtsova collaborates with scholars based in Canada, France and United States. Anna Roubtsova's co-authors include Nabil G. Seidah, Jadwiga Marcinkiewicz, Annik Prat, Ann Chamberland, Rachid Essalmani, Josée Hamelin, Weijun Jin, Jean Davignon, Ahmed Zaid and Hélène Jacques and has published in prestigious journals such as Journal of Biological Chemistry, Hepatology and Arteriosclerosis Thrombosis and Vascular Biology.

In The Last Decade

Anna Roubtsova

15 papers receiving 782 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anna Roubtsova Canada 11 608 199 143 137 109 17 786
Roland P.T. Troquay Netherlands 5 568 0.9× 225 1.1× 107 0.7× 148 1.1× 141 1.3× 6 820
JoAnn Flaim United States 10 848 1.4× 467 2.3× 106 0.7× 383 2.8× 440 4.0× 16 1.4k
D. Owensby Australia 14 193 0.3× 283 1.4× 65 0.5× 373 2.7× 59 0.5× 21 806
Nikolaos Tsavaris Greece 12 212 0.3× 166 0.8× 62 0.4× 290 2.1× 30 0.3× 19 596
Raimondo Di Liello Italy 13 71 0.1× 265 1.3× 87 0.6× 113 0.8× 44 0.4× 33 738
François Wilhelm United States 16 173 0.3× 270 1.4× 38 0.3× 90 0.7× 108 1.0× 64 796
Waheed Sangrar Canada 14 230 0.4× 215 1.1× 103 0.7× 178 1.3× 39 0.4× 24 591
Ruri Ohki Japan 13 155 0.3× 365 1.8× 92 0.6× 133 1.0× 43 0.4× 18 743
Tanja Ignatov Germany 22 113 0.2× 477 2.4× 61 0.4× 336 2.5× 55 0.5× 45 1.3k
Suman Bhattacharya United States 12 95 0.2× 346 1.7× 23 0.2× 370 2.7× 110 1.0× 26 1.2k

Countries citing papers authored by Anna Roubtsova

Since Specialization
Citations

This map shows the geographic impact of Anna Roubtsova's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Roubtsova with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Roubtsova more than expected).

Fields of papers citing papers by Anna Roubtsova

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Roubtsova. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Roubtsova. The network helps show where Anna Roubtsova may publish in the future.

Co-authorship network of co-authors of Anna Roubtsova

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Roubtsova. A scholar is included among the top collaborators of Anna Roubtsova based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Roubtsova. Anna Roubtsova is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Roubtsova, Anna, Hadi Bayat, Alexandra Evagelidis, et al.. (2025). Blockade of colon cancer metastasis via single and double silencing of PCSK7/PCSK9: enhanced T cells cytotoxicity in mouse and human. Journal for ImmunoTherapy of Cancer. 13(6). e011364–e011364.
2.
Platko, Khrystyna, Paul Lebeau, Melissa E. MacDonald, et al.. (2024). GDF10 is a negative regulator of vascular calcification. Journal of Biological Chemistry. 300(11). 107805–107805. 1 indexed citations
3.
Roubtsova, Anna, Corey A. Scipione, Michael B. Boffa, et al.. (2023). Surface LDLR is a major receptor for lipoprotein(a) clearance in male mice lacking PCSK9. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1868(4). 159288–159288. 3 indexed citations
4.
Roubtsova, Anna, Sandrine Lacoste, Ann Chamberland, et al.. (2022). PCSK9 deficiency results in a specific shedding of excess LDLR in female mice only: Role of hepatic cholesterol. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1867(12). 159217–159217. 14 indexed citations
5.
Moreau, F., Aurélie Thedrez, Audrey Ayer, et al.. (2021). PCSK9 is not secreted from mature differentiated intestinal cells. Journal of Lipid Research. 62. 100096–100096. 6 indexed citations
6.
Susan‐Resiga, Delia, Rachid Essalmani, Anna Roubtsova, et al.. (2021). Asialoglycoprotein receptor 1 is a novel PCSK9-independent ligand of liver LDLR cleaved by furin. Journal of Biological Chemistry. 297(4). 101177–101177. 19 indexed citations
7.
Peyot, Marie‐Line, Anna Roubtsova, Roxane Lussier, et al.. (2021). Substantial PCSK9 inactivation in β-cells does not modify glucose homeostasis or insulin secretion in mice. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids. 1866(8). 158968–158968. 25 indexed citations
8.
Essalmani, Rachid, Delia Susan‐Resiga, Anna Roubtsova, et al.. (2020). Proprotein convertase 7 (PCSK7) reduces apoA‐V levels. FEBS Journal. 287(16). 3565–3578. 15 indexed citations
9.
Moreau, F., Audrey Ayer, Wieneke Dijk, et al.. (2020). Circulating Rather Than Intestinal PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Regulates Postprandial Lipemia in Mice. Arteriosclerosis Thrombosis and Vascular Biology. 40(9). 2084–2094. 19 indexed citations
10.
Roubtsova, Anna, Marlys L. Koschinsky, Nabil G. Seidah, & Annik Prat. (2018). LDLR Activity and Subcellular Distribution is Sensitive to Estrogen in Mice Lacking PCSK9. Atherosclerosis Supplements. 32. 61–61.
11.
Essalmani, Rachid, Jadwiga Marcinkiewicz, Ann Chamberland, et al.. (2018). A single domain antibody against the Cys- and His-rich domain of PCSK9 and evolocumab exhibit different inhibition mechanisms in humanized PCSK9 mice. Biological Chemistry. 399(12). 1363–1374. 11 indexed citations
12.
Essalmani, Rachid, Jadwiga Marcinkiewicz, Josée Hamelin, et al.. (2018). The Proprotein Convertase 7 Regulates Triglyceride Levels via Enhanced ApoA5 Degradation. Atherosclerosis Supplements. 32. 56–56. 1 indexed citations
13.
Butkinaree, Chutikarn, Maryssa Canuel, Rachid Essalmani, et al.. (2015). Amyloid Precursor-like Protein 2 and Sortilin Do Not Regulate the PCSK9 Convertase-mediated Low Density Lipoprotein Receptor Degradation but Interact with Each Other. Journal of Biological Chemistry. 290(30). 18609–18620. 42 indexed citations
14.
Roubtsova, Anna, Ann Chamberland, Jadwiga Marcinkiewicz, et al.. (2015). PCSK9 deficiency unmasks a sex- and tissue-specific subcellular distribution of the LDL and VLDL receptors in mice. Journal of Lipid Research. 56(11). 2133–2142. 49 indexed citations
15.
Awan, Zuhier, Maxime Denis, Anna Roubtsova, et al.. (2015). Reducing Vascular Calcification by Anti-IL-1β Monoclonal Antibody in a Mouse Model of Familial Hypercholesterolemia. Angiology. 67(2). 157–167. 46 indexed citations
16.
Roubtsova, Anna, Mercedes N. Munkonda, Zuhier Awan, et al.. (2011). Circulating Proprotein Convertase Subtilisin/Kexin 9 (PCSK9) Regulates VLDLR Protein and Triglyceride Accumulation in Visceral Adipose Tissue. Arteriosclerosis Thrombosis and Vascular Biology. 31(4). 785–791. 203 indexed citations
17.
Zaid, Ahmed, Anna Roubtsova, Rachid Essalmani, et al.. (2008). Proprotein convertase subtilisin/kexin type 9 (PCSK9). Hepatology. 48(2). 646–654. 332 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Roland P.T. Troquay Breakdown of academic impact, for papers by JoAnn Flaim Breakdown of academic impact, for papers by D. Owensby Breakdown of academic impact, for papers by Nikolaos Tsavaris Breakdown of academic impact, for papers by Raimondo Di Liello Breakdown of academic impact, for papers by François Wilhelm Breakdown of academic impact, for papers by Waheed Sangrar Breakdown of academic impact, for papers by Ruri Ohki Breakdown of academic impact, for papers by Tanja Ignatov Breakdown of academic impact, for papers by Suman Bhattacharya
Rankless by CCL
2026